| |
INTENDED AUDIENCE
Retina specialists and ophthalmologists
LEARNING OBJECTIVES
Upon completion of this CME activity, the participant should be able to:
- Trace the history of optical coherence tomography (OCT) technology and discuss current innovations including spectral domain OCT
- Explain how OCT is used for different ocular diseases and discuss the value and limitations of the technology.
- Determine which patients should undergo OCT and discuss how the results should be used to manage treatment.
ACCREDITATION AND DESIGNATION STATEMENTS
 Rush University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Rush University Medical Center designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release Date: February 2010. The opinions or views expressed in this educational program are those of the participants and do not necessarily reflect the opinions or recommendations of Alcon Laboratories or Rush University Medical Center. The faculty may have included discussion on unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information before using any medication mentioned in this educational program. This program has been produced in compliance with all ACCME Essential Areas and Elements and Accreditation Policies.
Expiration Date: February 28, 2011.
RUSH DISCLOSURE POLICY
It is the policy of the Rush University Medical Center Office of Continuing Medical Education to ensure that its CME activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CME. Everyone who is in a position to control the content of an education activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months. If there are relationships that create a conflict of interest, these must be resolved by the CME Course Director in consultation with the Office of Continuing Medical Education prior to the participation of the faculty member in the development or presentation of course content.
 
|
 |
CME COURSE DIRECTOR
Kirk H. Packo, MD
Director, Department of Ophthalmology
Rush University Medical Center
Chicago, Illinois
FACULTY
Carmen A. Puliafito, MD, MBA
Dean, Keck School of Medicine
Professor of Ophthalmology
and Health Management
May S. and John Hooval
Dean's Chair in Medicine
University of Souther California
Los Angeles, California
DISCLOSURES
Kirk H. Packo, MD
Grant/Research/Support: Alcon Laboratories, Inc
Consultant: None
Speakers' Bureau: None
Stock Shareholder: None
Carmen A. Puliafito, MD, MBA
Grant/Research/Support: None
Consultant: Carl Zeiss Meditec
Speakers' Bureau: None
Stock Shareholder: None
|
|
